Related references
Note: Only part of the references are listed.Antioxidants Reduce Muscular Dystrophy in the dy(2J)/dy(2J) Mouse Model of Laminin alpha 2 Chain-Deficient Muscular Dystrophy
Vahid M. Harandi et al.
ANTIOXIDANTS (2020)
Pax7, Pax3 and Mamstr genes are involved in skeletal muscle impaired regeneration of dy2J/dy2J mouse model of Lama2-CMD
Nurit Yanay et al.
HUMAN MOLECULAR GENETICS (2019)
A mutation-independent approach for muscular dystrophy via upregulation of a modifier gene
Dwi U. Kemaladewi et al.
NATURE (2019)
Improvement of motor conduction velocity in hereditary neuropathy of LAMA2-CMD dy2J/dy2J mouse model by glatiramer acetate
Malcolm Rabie et al.
CLINICAL NEUROPHYSIOLOGY (2019)
Early skeletal muscle pathology and disease progress in the dy3K/ dy3K mouse model of congenital muscular dystrophy with laminin α2 chain-deficiency
Kinga Gawlik et al.
SCIENTIFIC REPORTS (2019)
RGD inhibition of itgb1 ameliorates laminin-α2-deficient zebrafish fibre pathology
Alasdair J. Wood et al.
HUMAN MOLECULAR GENETICS (2019)
Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy
Quynh Nguyen et al.
APPLICATION OF CLINICAL GENETICS (2019)
Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A
T. E. Hall et al.
NPJ REGENERATIVE MEDICINE (2019)
Laminin-deficient muscular dystrophy: Molecular pathogenesis and structural repair strategies
Peter D. Yurchenco et al.
MATRIX BIOLOGY (2018)
ELECTRICAL IMPEDANCE MYOGRAPHY IN INDIVIDUALS WITH COLLAGEN 6 AND LAMININ α-2 CONGENITAL MUSCULAR DYSTROPHY: A CROSS-SECTIONAL AND 2-YEAR ANALYSIS
Carmel Nichols et al.
MUSCLE & NERVE (2018)
Increased polyamines as protective disease modifiers in congenital muscular dystrophy
D. U. Kemaladewi et al.
HUMAN MOLECULAR GENETICS (2018)
At the Crossroads of Clinical and Preclinical Research for Muscular DystrophyAre We Closer to Effective Treatment for Patients?
Kinga I. Gawlik
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Laminin α1 reduces muscular dystrophy in dy2J mice
Kinga Gawlik et al.
MATRIX BIOLOGY (2018)
Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy
S. Pasteuning-Vuhman et al.
PLOS ONE (2018)
Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal
Shantisree Sandeepani Rayagiri et al.
NATURE COMMUNICATIONS (2018)
Amelioration of Muscle and Nerve Pathology in LAMA2 Muscular Dystrophy by AAV9-Mini-Agrin
Chunping Qiao et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
LAMA2 gene mutation update: Toward a more comprehensive picture of the laminin-α2 variome and its related phenotypes
Jorge Oliveira et al.
HUMAN MUTATION (2018)
Effects of metformin on congenital muscular dystrophy type 1A disease progression in mice: a gender impact study
Cibely C. Fontes-Oliveira et al.
SCIENTIFIC REPORTS (2018)
Impaired fetal muscle development and JAK-STAT activation mark disease onset and progression in a mouse model for merosin-deficient congenital muscular dystrophy
Andreia M. Nunes et al.
HUMAN MOLECULAR GENETICS (2017)
Chimeric protein repair of laminin polymerization ameliorates muscular dystrophy phenotype
Karen K. Mckee et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
Dwi U. Kemaladewi et al.
NATURE MEDICINE (2017)
Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
Bernardo Moreira Soares Oliveira et al.
PLOS ONE (2017)
Linker proteins restore basement membrane and correct LAMA2-related muscular dystrophy in mice
Judith R. Reinhard et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Fibrosis development in early-onset muscular dystrophies: Mechanisms and translational implications
Antonio L. Serrano et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Potent pro-inflammatory and pro-fibrotic molecules, osteopontin and galectin-3, are not major disease modulators of laminin α2 chain-deficient muscular dystrophy
Kinga I. Gawlik et al.
SCIENTIFIC REPORTS (2017)
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
Cibely C. Fontes-Oliveira et al.
SCIENTIFIC REPORTS (2017)
IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy
Anthony Accorsi et al.
HUMAN MOLECULAR GENETICS (2016)
Bortezomib Does Not Reduce Muscular Dystrophy in the dy2J/dy2J Mouse Model of Laminin α2 Chain-Deficient Muscular Dystrophy
Zandra Korner et al.
PLOS ONE (2016)
Musculoskeletal Geometry, Muscle Architecture and Functional Specialisations of the Mouse Hindlimb
James P. Charles et al.
PLOS ONE (2016)
Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A
M. Elbaz et al.
CELL DEATH & DISEASE (2015)
Deletion of integrin α7 subunit does not aggravate the phenotype of laminin α2 chain-deficient mice
Kinga I. Gawlik et al.
SCIENTIFIC REPORTS (2015)
Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A
Teuta Domi et al.
SKELETAL MUSCLE (2015)
Magnetic Resonance Imaging Is Sensitive to Pathological Amelioration in a Model for Laminin-Deficient Congenital Muscular Dystrophy (MDC1A)
Ravneet Vohra et al.
PLOS ONE (2015)
Bortezomib Partially Improves Laminin α2 Chain-Deficient Muscular Dystrophy
Zandra Korner et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Loss of Dystrophin and β-Sarcoglycan Significantly Exacerbates the Phenotype of Laminin α2 Chain-Deficient Animals
Kinga I. Gawlik et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy
Pam M. Van Ry et al.
HUMAN MOLECULAR GENETICS (2014)
The Extracellular Matrix Protein Laminin α2 Regulates the Maturation and Function of the Blood-Brain Barrier
Michael J. Menezes et al.
JOURNAL OF NEUROSCIENCE (2014)
Quantitative Proteomic Analysis Reveals Metabolic Alterations, Calcium Dysregulation, and Increased Expression of Extracellular Matrix Proteins in Laminin α2 Chain-deficient Muscle
Bruno Menezes de Oliveira et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
Diagnostic approach to the congenital muscular dystrophies
Carsten G. Boennemann et al.
NEUROMUSCULAR DISORDERS (2014)
Laminin α2 chain-deficiency is associated with microRNA deregulation in skeletal muscle and plasma
Johan Holmberg et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
Dysregulation of matricellular proteins is an early signature of pathology in laminin-deficient muscular dystrophy
Thomas Mehuron et al.
SKELETAL MUSCLE (2014)
Triggering regeneration and tackling apoptosis: a combinatorial approach to treating congenital muscular dystrophy type 1 A
Jenny Yamauchi et al.
HUMAN MOLECULAR GENETICS (2013)
Highly efficient in vivo delivery of PMO into regenerating myotubes and rescue in laminin-α2 chain-null congenital muscular dystrophy mice
Yoshitsugu Aoki et al.
HUMAN MOLECULAR GENETICS (2013)
Macrophage Plasticity and the Role of Inflammation in Skeletal Muscle Repair
Yacine Kharraz et al.
MEDIATORS OF INFLAMMATION (2013)
Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy
Qing Yu et al.
PLOS ONE (2013)
Laminin-111 Protein Therapy Reduces Muscle Pathology and Improves Viability of a Mouse Model of Merosin-Deficient Congenital Muscular Dystrophy
Jachinta E. Rooney et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the dy2J/dy2J Mouse
Moran Elbaz et al.
ANNALS OF NEUROLOGY (2012)
MKP-1 coordinates ordered macrophage-phenotype transitions essential for stem cell-dependent tissue repair
Eusebio Perdiguero et al.
CELL CYCLE (2012)
Epistatic dissection of lamininreceptor interactions in dystrophic zebrafish muscle
Tamar E. Sztal et al.
HUMAN MOLECULAR GENETICS (2012)
Schwann cell myelination requires integration of laminin activities
Karen K. Mckee et al.
JOURNAL OF CELL SCIENCE (2012)
A Splice Site Mutation in Laminin-α2 Results in a Severe Muscular Dystrophy and Growth Abnormalities in Zebrafish
Vandana A. Gupta et al.
PLOS ONE (2012)
Angiotensin II type 1 receptor antagonists alleviate muscle pathology in the mouse model for laminin-alpha 2-deficient congenital muscular dystrophy (MDC1A)
Sarina Meinen et al.
SKELETAL MUSCLE (2012)
Apoptosis inhibitors and mini-agrin have additive benefits in congenital muscular dystrophy mice
Sarina Meinen et al.
EMBO MOLECULAR MEDICINE (2011)
Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice
Virginie Carmignac et al.
HUMAN MOLECULAR GENETICS (2011)
Muscle-specific expression of insulin-like growth factor 1 improves outcome in Lama2Dy-w mice, a model for congenital muscular dystrophy type 1A
Ajay Kumar et al.
HUMAN MOLECULAR GENETICS (2011)
Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy
Sachiko Homma et al.
HUMAN MOLECULAR GENETICS (2011)
Autophagy is increased in laminin α2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A
Virginie Carmignac et al.
HUMAN MOLECULAR GENETICS (2011)
Transgenic overexpression of the α7 integrin reduces muscle pathology and improves viability in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1A
Jinger A. Doe et al.
JOURNAL OF CELL SCIENCE (2011)
Proinflammatory Signals and the Loss of Lymphatic Vessel Hyaluronan Receptor-1 (LYVE-1) in the Early Pathogenesis of Laminin Alpha2-deficient Skeletal Muscle
Katherine E. Wardrop et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies
Kinga I. Gawlik et al.
SKELETAL MUSCLE (2011)
TRANSGENIC OVEREXPRESSION OF LAMININ α1 CHAIN IN LAMININ α2 CHAIN-DEFICIENT MICE RESCUES THE DISEASE THROUGHOUT THE LIFESPAN
Kinga I. Gawlik et al.
MUSCLE & NERVE (2010)
FIBROSIS INHIBITION AND MUSCLE HISTOPATHOLOGY IMPROVEMENT IN LAMININ-α2-DEFICIENT MICE
Yoram Nevo et al.
MUSCLE & NERVE (2010)
Improved muscle strength and mobility in the dy2J/dy2J mouse with merosin deficient congenital muscular dystrophy treated with Glatiramer acetate
Oshrat Dadush et al.
NEUROMUSCULAR DISORDERS (2010)
Distinct Roles for Laminin Globular Domains in Laminin α1 Chain Mediated Rescue of Murine Laminin α2 Chain Deficiency
Kinga I. Gawlik et al.
PLOS ONE (2010)
Pathology Is Alleviated by Doxycycline in a Laminin-alpha 2-Null Model of Congenital Muscular Dystrophy
Mahasweta Girgenrath et al.
ANNALS OF NEUROLOGY (2009)
Developmental and Pathogenic Mechanisms of Basement Membrane Assembly
Peter D. Yurchenco et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Omigapil Ameliorates the Pathology of Muscle Dystrophy Caused by Laminin-α2 Deficiency
Michael Erb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
INTRINSIC LARYNGEAL MUSCLES ARE SPARED FROM DEGENERATION IN THE dy(3K)/dy(3K) MOUSE MODEL OF CONGENITAL MUSCULAR DYSTROPHY TYPE 1A
Mattias Hager et al.
MUSCLE & NERVE (2009)
CD90-positive cells, an additional cell population, produce laminin alpha 2 upon transplantation to dy(3k)/dy(3k) mice
So-ichiro Fukada et al.
EXPERIMENTAL CELL RESEARCH (2008)
Cib2 binds integrin α7Bβ1D and is reduced in laminin α2 chain-deficient muscular dystrophy
Mattias Haeger et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
A single point mutation in the LN domain of LAMA2 causes muscular dystrophy and peripheral amyelination
Bruce L. Patton et al.
JOURNAL OF CELL SCIENCE (2008)
Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy
Douglas P. Millay et al.
NATURE MEDICINE (2008)
Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyw mouse model of congenital muscular dystrophy 1A
Rui Xu et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Linker molecules between laminins and dystroglycan ameliorate laminin-α2-deficient muscular dystrophy at all disease stages
Sarina Meinen et al.
JOURNAL OF CELL BIOLOGY (2007)
Laminin α1 chain improves laminin α2 chain deficient peripheral neuropathy
Kinga I. Gawlik et al.
HUMAN MOLECULAR GENETICS (2006)
Bone marrow transplantation improves outcome in a mouse model of congenital muscular dystrophy
Hiroki Hagiwara et al.
FEBS LETTERS (2006)
Extraocular muscle is spared upon complete laminin α2 chain deficiency:: Comparative expression of laminin and integrin isoforms
Alexander Nystrom et al.
MATRIX BIOLOGY (2006)
Laminin α1 chain mediated reduction of laminin α2 chain deficient muscular dystrophy involves integrin α7β1 and dystroglycan
KI Gawlik et al.
FEBS LETTERS (2006)
Gene expression profiling of diaphragm muscle in α2-laminin (merosin)-deficient dy/dy dystrophic mice
E van Lunteren et al.
PHYSIOLOGICAL GENOMICS (2006)
ADAM 12 overexpression does not improve outcome in mice with laminin α2-deficient muscular dystrophy
LT Guo et al.
NEUROMUSCULAR DISORDERS (2005)
Laminin α1 chain corrects male infertility caused by absence of laminin α2 chain
M Häger et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Amelioration of laminin-α2-deficient congenital muscular dystrophy by somatic gene transfer of miniagrin
CP Qiao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Overexpression of mini-agrin in skeletal muscle increases muscle integrity and regenerative capacity in laminin-α2-deficient mice
CF Bentzinger et al.
FASEB JOURNAL (2005)
Diseased muscles that lack dystrophin or laminin-α2 have altered compositions and proliferation of mononuclear cell populations -: art. no. 7
M Girgenrath et al.
BMC NEUROLOGY (2005)
Coordinate control of axon defasciculation and myelination by laminin-2 and-8
DR Yang et al.
JOURNAL OF CELL BIOLOGY (2005)
Elimination of myostatin does not combat muscular dystrophy in dy mice but increases postnatal lethality
ZF Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Laminin α2 is essential for odontoblast differentiation regulating dentin sialoprotein expression
K Yuasa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Loss of basement membrane, receptor and cytoskeletal lattices in a laminin-deficient muscular dystrophy
PD Yurchenco et al.
JOURNAL OF CELL SCIENCE (2004)
Laminins α2 and α4 in pancreatic acinar basement membranes are required for basal receptor localization
JH Miner et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice
K Gawlik et al.
HUMAN MOLECULAR GENETICS (2004)
Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination
SJ Chun et al.
JOURNAL OF CELL BIOLOGY (2003)
Opposing roles of integrin α6Aβ1 and dystroglycan in laminin-mediated extracellular signal-regulated kinase activation
M Ferletta et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Spontaneous muscular dystrophy caused by a retrotransposal insertion in the mouse laminin α2 chain gene
S Besse et al.
NEUROMUSCULAR DISORDERS (2003)
Laminin α2 deficiency and muscular dystrophy;: genotype-phenotype correlation in mutant mice
LT Guo et al.
NEUROMUSCULAR DISORDERS (2003)
Hearing loss in the laminin-deficient dy mouse model of congenital muscular dystrophy
DM Pillers et al.
MOLECULAR GENETICS AND METABOLISM (2002)
Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin α2-deficient mice
AM Connolly et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Three mouse models of muscular dystrophy:: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin α2-deficient mice
AM Connolly et al.
NEUROMUSCULAR DISORDERS (2001)
The expanding phenotype of laminin α2 chain (merosin) abnormalities:: case series and review
KJ Jones et al.
JOURNAL OF MEDICAL GENETICS (2001)
An agrin minigene rescues dystrophic symptoms in a mouse model for congenital muscular dystrophy
J Moll et al.
NATURE (2001)
Schwann cell myelination occurred without basal lamina formation in laminin α2 chain-null mutant (dy3K/dy3K) mice
M Nakagawa et al.
GLIA (2001)
Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy
YK Hayashi et al.
NEUROMUSCULAR DISORDERS (2001)
Structural and functional analysis of the recombinant G domain of the laminin α4 chain and its proteolytic processing in tissues
JF Talts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
